These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11063789)

  • 1. Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women.
    Terao T; Nakamura J; Yoshimura R; Ohmori O; Takahashi N; Kojima H; Soeda S; Shinkai T; Nakano H; Okuno T
    Psychiatry Res; 2000 Oct; 96(2):167-73. PubMed ID: 11063789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
    Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
    Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.
    Bagdy G; Arato M
    Psychopharmacology (Berl); 1998 Apr; 136(4):342-8. PubMed ID: 9600579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated.
    Gordon ML; Lipton RB; Brown SL; Nakraseive C; Russell M; Pollack SZ; Korn ML; Merriam A; Solomon S; van Praag HM
    Cephalalgia; 1993 Dec; 13(6):400-5. PubMed ID: 8313453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.
    Pallanti S; Bernardi S; Quercioli L; DeCaria C; Hollander E
    CNS Spectr; 2006 Dec; 11(12):956-64. PubMed ID: 17146409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA; Murphy DL; Sunderland T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
    Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
    Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.
    Scheepers FE; Gespen de Wied CC; Kahn RS
    J Clin Psychopharmacol; 2001 Dec; 21(6):575-82. PubMed ID: 11763004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of serotonin function in anorexia nervosa.
    Brewerton TD; Jimerson DC
    Psychiatry Res; 1996 Apr; 62(1):31-42. PubMed ID: 8739113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
    Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.
    D'Souza DC; Gil RB; Zuzarte E; MacDougall LM; Donahue L; Ebersole JS; Boutros NN; Cooper T; Seibyl J; Krystal JH
    Biol Psychiatry; 2006 Jan; 59(2):128-37. PubMed ID: 16140281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus.
    Nappi RE; Sances G; Brundu B; Ghiotto N; Detaddei S; Biancardi C; Polatti F; Nappi G
    Neuroendocrinology; 2003 Jul; 78(1):52-60. PubMed ID: 12869800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
    Levitan RD; Kaplan AS; Joffe RT; Levitt AJ; Brown GM
    Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
    Benjamin J; Greenberg BD; Murphy DL
    Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
    Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
    Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.